178 related articles for article (PubMed ID: 32019329)
21. Faster Compared With Standard Insulin Aspart During Day-and-Night Fully Closed-Loop Insulin Therapy in Type 1 Diabetes: A Double-Blind Randomized Crossover Trial.
Dovc K; Piona C; Yeşiltepe Mutlu G; Bratina N; Jenko Bizjan B; Lepej D; Nimri R; Atlas E; Muller I; Kordonouri O; Biester T; Danne T; Phillip M; Battelino T
Diabetes Care; 2020 Jan; 43(1):29-36. PubMed ID: 31575640
[TBL] [Abstract][Full Text] [Related]
22. One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes.
Petrovski G; Al Khalaf F; Campbell J; Umer F; Almajaly D; Hamdan M; Hussain K
Acta Diabetol; 2021 Feb; 58(2):207-213. PubMed ID: 33044604
[TBL] [Abstract][Full Text] [Related]
23. Closed-Loop Control of Postprandial Glycemia Using an Insulin-on-Board Limitation Through Continuous Action on Glucose Target.
Rossetti P; Quirós C; Moscardó V; Comas A; Giménez M; Ampudia-Blasco FJ; León F; Montaser E; Conget I; Bondia J; Vehí J
Diabetes Technol Ther; 2017 Jun; 19(6):355-362. PubMed ID: 28459603
[TBL] [Abstract][Full Text] [Related]
24. Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting.
Barnard KD; Wysocki T; Thabit H; Evans ML; Amiel S; Heller S; Young A; Hovorka R;
Diabet Med; 2015 May; 32(5):601-8. PubMed ID: 25615888
[TBL] [Abstract][Full Text] [Related]
25. Semi-closed-loop insulin delivery systems: early experience with low-glucose insulin suspend pumps.
Pickup JC
Diabetes Technol Ther; 2011 Jul; 13(7):695-8. PubMed ID: 21668344
[No Abstract] [Full Text] [Related]
26. Patient Input for Design of a Decision Support Smartphone Application for Type 1 Diabetes.
Wilson LM; Tyler N; Jacobs PG; Gabo V; Senf B; Reddy R; Castle JR
J Diabetes Sci Technol; 2020 Nov; 14(6):1081-1087. PubMed ID: 31441336
[TBL] [Abstract][Full Text] [Related]
27. Mitigating Meal-Related Glycemic Excursions in an Insulin-Sparing Manner During Closed-Loop Insulin Delivery: The Beneficial Effects of Adjunctive Pramlintide and Liraglutide.
Sherr JL; Patel NS; Michaud CI; Palau-Collazo MM; Van Name MA; Tamborlane WV; Cengiz E; Carria LR; Tichy EM; Weinzimer SA
Diabetes Care; 2016 Jul; 39(7):1127-34. PubMed ID: 27208332
[TBL] [Abstract][Full Text] [Related]
28. Do-It-Yourself Automated Insulin Delivery: A Leading Example of the Democratization of Medicine.
Burnside M; Crocket H; Mayo M; Pickering J; Tappe A; de Bock M
J Diabetes Sci Technol; 2020 Sep; 14(5):878-882. PubMed ID: 31876179
[TBL] [Abstract][Full Text] [Related]
29. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
[TBL] [Abstract][Full Text] [Related]
30. The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial.
Nimri R; Danne T; Kordonouri O; Atlas E; Bratina N; Biester T; Avbelj M; Miller S; Muller I; Phillip M; Battelino T
Pediatr Diabetes; 2013 May; 14(3):159-67. PubMed ID: 23448393
[TBL] [Abstract][Full Text] [Related]
31. Closing the Loop on Managing Youth With Type 1 Diabetes: Children Are Not Just Small Adults.
Sherr JL
Diabetes Care; 2018 Aug; 41(8):1572-1578. PubMed ID: 29936422
[TBL] [Abstract][Full Text] [Related]
32. Dual-Hormone Closed-Loop System Using a Liquid Stable Glucagon Formulation Versus Insulin-Only Closed-Loop System Compared With a Predictive Low Glucose Suspend System: An Open-Label, Outpatient, Single-Center, Crossover, Randomized Controlled Trial.
Wilson LM; Jacobs PG; Ramsey KL; Resalat N; Reddy R; Branigan D; Leitschuh J; Gabo V; Guillot F; Senf B; El Youssef J; Steineck IIK; Tyler NS; Castle JR
Diabetes Care; 2020 Nov; 43(11):2721-2729. PubMed ID: 32907828
[TBL] [Abstract][Full Text] [Related]
33. Participants' Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Real Life Settings: Longitudinal Qualitative Study.
Lawton J; Blackburn M; Rankin D; Allen JM; Campbell FM; Leelarathna L; Tauschmann M; Thabit H; Wilinska ME; Elleri D; Hovorka R
Diabetes Technol Ther; 2019 Mar; 21(3):119-127. PubMed ID: 30720338
[TBL] [Abstract][Full Text] [Related]
34. First Look at Control-IQ: A New-Generation Automated Insulin Delivery System.
Brown S; Raghinaru D; Emory E; Kovatchev B
Diabetes Care; 2018 Dec; 41(12):2634-2636. PubMed ID: 30305346
[TBL] [Abstract][Full Text] [Related]
35. Psychological outcomes of evening and night closed-loop insulin delivery under free living conditions in people with Type 1 diabetes: a 2-month randomized crossover trial.
Kropff J; DeJong J; Del Favero S; Place J; Messori M; Coestier B; Farret A; Boscari F; Galasso S; Avogaro A; Bruttomesso D; Cobelli C; Renard E; Magni L; DeVries JH;
Diabet Med; 2017 Feb; 34(2):262-271. PubMed ID: 27696520
[TBL] [Abstract][Full Text] [Related]
36. INSULIN TIMING: A PATIENT-CENTERED APPROACH TO IMPROVE CONTROL IN TYPE 1 DIABETES.
Duran-Valdez E; Burge MR; Broderick P; Shey L; Valentine V; Schrader RM; Schade DS
Endocr Pract; 2017 Apr; 23(4):471-478. PubMed ID: 28156154
[TBL] [Abstract][Full Text] [Related]
37. Exploring Parental Experiences of Using a Do-It-Yourself Solution for Continuous Glucose Monitoring Among Children and Adolescents With Type 1 Diabetes: A Qualitative Study.
Elbalshy M; Boucher S; Crocket H; Galland B; MacKenzie C; de Bock MI; Jefferies C; Wiltshire E; Wheeler BJ
J Diabetes Sci Technol; 2020 Sep; 14(5):844-853. PubMed ID: 31875411
[TBL] [Abstract][Full Text] [Related]
38. Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at Home.
Renard E; Farret A; Kropff J; Bruttomesso D; Messori M; Place J; Visentin R; Calore R; Toffanin C; Di Palma F; Lanzola G; Magni P; Boscari F; Galasso S; Avogaro A; Keith-Hynes P; Kovatchev B; Del Favero S; Cobelli C; Magni L; DeVries JH;
Diabetes Care; 2016 Jul; 39(7):1151-60. PubMed ID: 27208331
[TBL] [Abstract][Full Text] [Related]
39. Lower Daily Carbohydrate Intake Is Associated With Improved Glycemic Control in Adults With Type 1 Diabetes Using a Hybrid Closed-Loop System.
Lehmann V; Zueger T; Zeder A; Scott S; Bally L; Laimer M; Stettler C
Diabetes Care; 2020 Dec; 43(12):3102-3105. PubMed ID: 32998989
[TBL] [Abstract][Full Text] [Related]
40. Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes.
Lal RA; Ekhlaspour L; Hood K; Buckingham B
Endocr Rev; 2019 Dec; 40(6):1521-1546. PubMed ID: 31276160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
